Form 8-K - Current report:
SEC Accession No. 0001213900-25-002831
Filing Date
2025-01-13
Accepted
2025-01-13 07:35:34
Documents
44
Period of Report
2025-01-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227480-8k_kyverna.htm   iXBRL 8-K 30793
2 PRESS RELEASE ISSUED BY KYVERNA THERAPEUTICS, INC., DATED JANUARY 13, 2025 ea022748001ex99-1_kyverna.htm EX-99.1 28720
3 KYVERNA THERAPEUTICS, INC. PRESENTATION - PIONEERING CAR T IN AUTOIMMUNE DISEASE ea022748001ex99-2_kyverna.htm EX-99.2 35804
4 GRAPHIC ex99-2_001.jpg GRAPHIC 467079
5 GRAPHIC ex99-2_002.jpg GRAPHIC 918948
6 GRAPHIC ex99-2_003.jpg GRAPHIC 574193
7 GRAPHIC ex99-2_004.jpg GRAPHIC 471690
8 GRAPHIC ex99-2_005.jpg GRAPHIC 489297
9 GRAPHIC ex99-2_006.jpg GRAPHIC 503885
10 GRAPHIC ex99-2_007.jpg GRAPHIC 529540
11 GRAPHIC ex99-2_008.jpg GRAPHIC 537319
12 GRAPHIC ex99-2_009.jpg GRAPHIC 502607
13 GRAPHIC ex99-2_010.jpg GRAPHIC 462158
14 GRAPHIC ex99-2_011.jpg GRAPHIC 523113
15 GRAPHIC ex99-2_012.jpg GRAPHIC 547088
16 GRAPHIC ex99-2_013.jpg GRAPHIC 669384
17 GRAPHIC ex99-2_014.jpg GRAPHIC 919123
18 GRAPHIC ex99-2_015.jpg GRAPHIC 947222
19 GRAPHIC ex99-2_016.jpg GRAPHIC 634887
20 GRAPHIC ex99-2_017.jpg GRAPHIC 454155
21 GRAPHIC ex99-2_018.jpg GRAPHIC 441791
22 GRAPHIC ex99-2_019.jpg GRAPHIC 449677
23 GRAPHIC ex99-2_020.jpg GRAPHIC 414919
24 GRAPHIC ex99-2_021.jpg GRAPHIC 345079
25 GRAPHIC ex99-2_022.jpg GRAPHIC 434871
26 GRAPHIC ex99-2_023.jpg GRAPHIC 365650
27 GRAPHIC ex99-2_024.jpg GRAPHIC 786780
28 GRAPHIC ex99-2_025.jpg GRAPHIC 393834
29 GRAPHIC ex99-2_026.jpg GRAPHIC 557537
30 GRAPHIC ex99-2_027.jpg GRAPHIC 607269
31 GRAPHIC ex99-2_028.jpg GRAPHIC 632776
32 GRAPHIC ex99-2_029.jpg GRAPHIC 303114
  Complete submission text file 0001213900-25-002831.txt   22165858

Data Files

Seq Description Document Type Size
33 XBRL SCHEMA FILE kytx-20250113.xsd EX-101.SCH 3018
34 XBRL LABEL FILE kytx-20250113_lab.xml EX-101.LAB 34240
35 XBRL PRESENTATION FILE kytx-20250113_pre.xml EX-101.PRE 22361
46 EXTRACTED XBRL INSTANCE DOCUMENT ea0227480-8k_kyverna_htm.xml XML 3689
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

EIN.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41947 | Film No.: 25524820
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)